Alzheimer's disease (AD) currently presents one of the biggest healthcare issues in the
developed countries. There is no effective treatment capable of slowing down disease …

Current understanding on the mechanisms of brain injury and neurodegeneration highlights
an appreciation of multicellular interactions within the neurovascular unit (NVU), which …

Background Older people suffering from dementia are at increased risk of malnutrition due
to various nutritional problems, and the question arises which interventions are effective in …

Background Alzheimer disease (AD) patients are at risk of nutritional insufficiencies because
of physiological and psychological factors. Nutritional compounds are postulated to play a …

It is the position of the Academy of Nutrition and Dietetics that all Americans aged 60 years
and older receive appropriate nutrition care; have access to coordinated, comprehensive …

Souvenaid aims to improve synapse formation and function. An earlier study in patients with
Alzheimer's disease (AD) showed that Souvenaid increased memory performance after 12 …

Mild cognitive impairment (MCI) is defined as an intermediate state between normal
cognitive aging and dementia. It describes a status of the subjective impression of cognitive …

Alzheimer's disease is a progressive neurodegenerative disorder, characterized by
deposition of amyloid beta, neurofibrillary tangles, astrogliosis and microgliosis, leading to …

As people age they become increasingly susceptible to chronic and extremely debilitating
brain diseases. The precise cause of the neuronal degeneration underlying these disorders …

A randomized trial (VITACOG) in people with mild cognitive impairment (MCI) found that B
vitamin treatment to lower homocysteine slowed the rate of cognitive and clinical decline …